SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Crucell N.V. (CRXL) -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (550)9/28/2009 10:00:12 AM
From: tom pope  Respond to of 560
 
Says something about the takeover expectation premium built into some of these biotechs.



To: nigel bates who wrote (550)9/28/2009 10:36:50 AM
From: pgo-neil  Respond to of 560
 
>Possibly because people think this might limit any takeout price, or defer it ?<

Good point and also reinforced by Tom's observation about the takeover premium already priced in. Down over 5% on what seems like good news, more cash, some partnering and milestone payments, a marketing powerhouse to sell products...

graham
--